Level Four Advisory Services LLC Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Level Four Advisory Services LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 894 shares of the medical equipment provider’s stock after buying an additional 138 shares during the quarter. Level Four Advisory Services LLC’s holdings in Intuitive Surgical were worth $467,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Vertex Planning Partners LLC boosted its stake in Intuitive Surgical by 3.7% in the 4th quarter. Vertex Planning Partners LLC now owns 851 shares of the medical equipment provider’s stock worth $444,000 after purchasing an additional 30 shares in the last quarter. Orion Portfolio Solutions LLC lifted its stake in shares of Intuitive Surgical by 1.6% in the fourth quarter. Orion Portfolio Solutions LLC now owns 13,059 shares of the medical equipment provider’s stock worth $6,816,000 after buying an additional 204 shares in the last quarter. New Age Alpha Advisors LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $1,098,000. Norges Bank bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $2,401,493,000. Finally, Blair William & Co. IL raised its holdings in Intuitive Surgical by 0.9% in the 4th quarter. Blair William & Co. IL now owns 468,880 shares of the medical equipment provider’s stock worth $244,737,000 after acquiring an additional 4,101 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent analyst reports. Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Citigroup upped their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $495.27 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a fifty day moving average price of $554.33 and a 200-day moving average price of $532.98. The stock has a market cap of $176.40 billion, a PE ratio of 77.27, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.